Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives

Human cytomegalovirus (HCMV) infection is associated with severe morbidity and mortality in immunocompromised individuals, mainly transplant recipients and AIDS patients, and is the most frequent cause of congenital malformations in newborn children. To date, few drugs are licensed for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercorelli, Beatrice, Lembo, David, Palù, Giorgio, Loregian, Arianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112563/
https://www.ncbi.nlm.nih.gov/pubmed/21570424
http://dx.doi.org/10.1016/j.pharmthera.2011.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112563/
https://www.ncbi.nlm.nih.gov/pubmed/21570424
http://dx.doi.org/10.1016/j.pharmthera.2011.04.007

Ejemplares similares